Advertisement
Table 2 The differences of the disease duration, the H&Y stage, the L-dopa equivalent dose, and the UPDRS scores and subscores among PDSS-identified sleep disturbances
| items | Groups | |||||
|---|---|---|---|---|---|---|
| Score ≤ 90 (n = 26) | 91 ~ 104(n = 24) | ≥105(n = 86) | ||||
| Mean (SD) | Min-Max | Mean (SD) | Min-Max | Mean (SD) | Min-Max | |
| Male. n (%) | 15(17.6) | 15(17.6) | 55(64.7) | |||
| Age at visit, years | 63.42(2.68) | 34-87 | 70.42(1.48) | 51-88 | 62.71(1.22) | 29-80 |
| Age at onset, years | 54.21(2.84) | 27.5-81 | 64.54(1.97) | 40-81 | 57.68(1.27) | 27.5-78 |
| Disease duration** | 9.21(6.14) | 0.5-27 | 5.88(5.59) | 1-27 | 5.03(4.09) | 0.5-20 |
| H&Y stage** | 2.62(0.90) | 1-4 | 2.38(0.77) | 1-4 | 1.95(0.75) | 1-4 |
| Levodopa* | 494(208) | 100-950 | 339(233) | 0-786 | 360(261) | 0-1196 |
| UPDRS score** | 56.19(29.93) | 19-141 | 48.46(26.75) | 18-121 | 36.72(17.36) | 10-111 |
| Daily life activity* | 16.85(8.68) | 6-41 | 14.96(8.93) | 6-37 | 11.44(5.11) | 3-33 |
| Motor function** | 36.27(21.06) | 3-91 | 32.33(18.27) | 10-83 | 24.00(12.30) | 4-73 |
| Tremor* | 5.96(5.42) | 0-20 | 5.58(3.87) | 0-15 | 3.53(3.05) | 0-14 |
| Rigidity** | 8.46(4.55) | 0-19 | 6.17(4.58) | 0-17 | 5.26(3.44) | 0-15 |
| bradykinesia | 13.54(8.58) | 1-30 | 12.04(8.61) | 1-36 | 9.27(6.23) | 0-36 |
| Gait/postural stability* | 5.23(3.73) | 0-15 | 5.38(3.82) | 0-16 | 3.61(2.95) | 0-16 |
| Bulbar abnormalities** | 3.08(1.35) | 1-7 | 3.17(1.63) | 0-8 | 2.33(0.99) | 0-5 |
| Complication** | 3.08(2.62) | 0-9 | 1.17(1.09) | 0-4 | 1.28(1.97) | 0-11 |
| Motor fluctuation** | 1.46(1.96) | 0-7 | 0.04(0.2) | 0-1 | 0.44(1.06) | 0-4 |
| Dyskinesia | 0.50(1.03) | 0-4 | 0.17(0.64) | 0-3 | 0.26(0.84) | 0-6 |
